nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP2D6—Tamoxifen—pancreatic cancer	0.0947	0.203	CbGbCtD
Ranolazine—CYP2D6—Erlotinib—pancreatic cancer	0.0805	0.173	CbGbCtD
Ranolazine—CYP3A4—Tamoxifen—pancreatic cancer	0.0602	0.129	CbGbCtD
Ranolazine—CYP3A4—Erlotinib—pancreatic cancer	0.0512	0.11	CbGbCtD
Ranolazine—CYP3A4—Irinotecan—pancreatic cancer	0.0462	0.0994	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—pancreatic cancer	0.0397	0.0854	CbGbCtD
Ranolazine—CYP3A4—Docetaxel—pancreatic cancer	0.0339	0.0728	CbGbCtD
Ranolazine—CYP3A4—Sunitinib—pancreatic cancer	0.0337	0.0725	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—pancreatic cancer	0.0253	0.0543	CbGbCtD
Ranolazine—Carvedilol—HIF1A—pancreatic cancer	0.00714	0.713	CrCbGaD
Ranolazine—Carvedilol—VEGFA—pancreatic cancer	0.00288	0.287	CrCbGaD
Ranolazine—Insomnia—Irinotecan—pancreatic cancer	0.0008	0.00153	CcSEcCtD
Ranolazine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000799	0.00152	CcSEcCtD
Ranolazine—Vomiting—Tamoxifen—pancreatic cancer	0.000797	0.00152	CcSEcCtD
Ranolazine—Paraesthesia—Irinotecan—pancreatic cancer	0.000794	0.00151	CcSEcCtD
Ranolazine—Lethargy—Doxorubicin—pancreatic cancer	0.000792	0.00151	CcSEcCtD
Ranolazine—Hypotension—Fluorouracil—pancreatic cancer	0.000792	0.00151	CcSEcCtD
Ranolazine—Rash—Tamoxifen—pancreatic cancer	0.000791	0.00151	CcSEcCtD
Ranolazine—Dermatitis—Tamoxifen—pancreatic cancer	0.00079	0.00151	CcSEcCtD
Ranolazine—Vomiting—Erlotinib—pancreatic cancer	0.000789	0.0015	CcSEcCtD
Ranolazine—Dyspnoea—Irinotecan—pancreatic cancer	0.000789	0.0015	CcSEcCtD
Ranolazine—Somnolence—Irinotecan—pancreatic cancer	0.000786	0.0015	CcSEcCtD
Ranolazine—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000786	0.0015	CcSEcCtD
Ranolazine—Headache—Tamoxifen—pancreatic cancer	0.000785	0.0015	CcSEcCtD
Ranolazine—Rash—Erlotinib—pancreatic cancer	0.000782	0.00149	CcSEcCtD
Ranolazine—Dermatitis—Erlotinib—pancreatic cancer	0.000781	0.00149	CcSEcCtD
Ranolazine—Angiopathy—Docetaxel—pancreatic cancer	0.000781	0.00149	CcSEcCtD
Ranolazine—Dehydration—Epirubicin—pancreatic cancer	0.00078	0.00149	CcSEcCtD
Ranolazine—Insomnia—Gemcitabine—pancreatic cancer	0.000779	0.00149	CcSEcCtD
Ranolazine—Dyspepsia—Irinotecan—pancreatic cancer	0.000779	0.00148	CcSEcCtD
Ranolazine—Headache—Erlotinib—pancreatic cancer	0.000777	0.00148	CcSEcCtD
Ranolazine—Diplopia—Doxorubicin—pancreatic cancer	0.000776	0.00148	CcSEcCtD
Ranolazine—Pain in extremity—Doxorubicin—pancreatic cancer	0.000776	0.00148	CcSEcCtD
Ranolazine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000776	0.00148	CcSEcCtD
Ranolazine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000774	0.00148	CcSEcCtD
Ranolazine—Asthenia—Sunitinib—pancreatic cancer	0.00077	0.00147	CcSEcCtD
Ranolazine—Decreased appetite—Irinotecan—pancreatic cancer	0.000769	0.00147	CcSEcCtD
Ranolazine—Arrhythmia—Docetaxel—pancreatic cancer	0.000769	0.00147	CcSEcCtD
Ranolazine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000768	0.00146	CcSEcCtD
Ranolazine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000766	0.00146	CcSEcCtD
Ranolazine—Insomnia—Fluorouracil—pancreatic cancer	0.000766	0.00146	CcSEcCtD
Ranolazine—Somnolence—Gemcitabine—pancreatic cancer	0.000766	0.00146	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000764	0.00146	CcSEcCtD
Ranolazine—Fatigue—Irinotecan—pancreatic cancer	0.000763	0.00145	CcSEcCtD
Ranolazine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000761	0.00145	CcSEcCtD
Ranolazine—Pruritus—Sunitinib—pancreatic cancer	0.00076	0.00145	CcSEcCtD
Ranolazine—Breast disorder—Epirubicin—pancreatic cancer	0.000758	0.00145	CcSEcCtD
Ranolazine—Constipation—Irinotecan—pancreatic cancer	0.000756	0.00144	CcSEcCtD
Ranolazine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000755	0.00144	CcSEcCtD
Ranolazine—Mental disorder—Docetaxel—pancreatic cancer	0.000754	0.00144	CcSEcCtD
Ranolazine—Somnolence—Fluorouracil—pancreatic cancer	0.000753	0.00144	CcSEcCtD
Ranolazine—Malnutrition—Docetaxel—pancreatic cancer	0.000749	0.00143	CcSEcCtD
Ranolazine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000749	0.00143	CcSEcCtD
Ranolazine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000746	0.00142	CcSEcCtD
Ranolazine—Nausea—Tamoxifen—pancreatic cancer	0.000745	0.00142	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000744	0.00142	CcSEcCtD
Ranolazine—Fatigue—Gemcitabine—pancreatic cancer	0.000743	0.00142	CcSEcCtD
Ranolazine—Constipation—Gemcitabine—pancreatic cancer	0.000737	0.0014	CcSEcCtD
Ranolazine—Nausea—Erlotinib—pancreatic cancer	0.000737	0.0014	CcSEcCtD
Ranolazine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000736	0.0014	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000731	0.00139	CcSEcCtD
Ranolazine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000729	0.00139	CcSEcCtD
Ranolazine—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000727	0.00139	CcSEcCtD
Ranolazine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000723	0.00138	CcSEcCtD
Ranolazine—Dehydration—Doxorubicin—pancreatic cancer	0.000722	0.00138	CcSEcCtD
Ranolazine—Muscle spasms—Docetaxel—pancreatic cancer	0.00072	0.00137	CcSEcCtD
Ranolazine—Eosinophilia—Epirubicin—pancreatic cancer	0.000718	0.00137	CcSEcCtD
Ranolazine—Pancreatitis—Epirubicin—pancreatic cancer	0.000711	0.00136	CcSEcCtD
Ranolazine—Dizziness—Sunitinib—pancreatic cancer	0.00071	0.00135	CcSEcCtD
Ranolazine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00071	0.00135	CcSEcCtD
Ranolazine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000709	0.00135	CcSEcCtD
Ranolazine—Breast disorder—Doxorubicin—pancreatic cancer	0.000702	0.00134	CcSEcCtD
Ranolazine—Abdominal pain—Irinotecan—pancreatic cancer	0.000699	0.00133	CcSEcCtD
Ranolazine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000698	0.00133	CcSEcCtD
Ranolazine—Pancytopenia—Epirubicin—pancreatic cancer	0.000689	0.00131	CcSEcCtD
Ranolazine—Vomiting—Sunitinib—pancreatic cancer	0.000683	0.0013	CcSEcCtD
Ranolazine—Dysuria—Epirubicin—pancreatic cancer	0.000678	0.00129	CcSEcCtD
Ranolazine—Rash—Sunitinib—pancreatic cancer	0.000677	0.00129	CcSEcCtD
Ranolazine—Dermatitis—Sunitinib—pancreatic cancer	0.000676	0.00129	CcSEcCtD
Ranolazine—Urticaria—Fluorouracil—pancreatic cancer	0.000673	0.00128	CcSEcCtD
Ranolazine—Headache—Sunitinib—pancreatic cancer	0.000673	0.00128	CcSEcCtD
Ranolazine—Syncope—Docetaxel—pancreatic cancer	0.000672	0.00128	CcSEcCtD
Ranolazine—Leukopenia—Docetaxel—pancreatic cancer	0.000671	0.00128	CcSEcCtD
Ranolazine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000664	0.00127	CcSEcCtD
Ranolazine—Palpitations—Docetaxel—pancreatic cancer	0.000662	0.00126	CcSEcCtD
Ranolazine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000659	0.00126	CcSEcCtD
Ranolazine—Pancreatitis—Doxorubicin—pancreatic cancer	0.000658	0.00125	CcSEcCtD
Ranolazine—Weight decreased—Epirubicin—pancreatic cancer	0.000656	0.00125	CcSEcCtD
Ranolazine—Cough—Docetaxel—pancreatic cancer	0.000654	0.00125	CcSEcCtD
Ranolazine—Nausea—Sunitinib—pancreatic cancer	0.000638	0.00122	CcSEcCtD
Ranolazine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000637	0.00121	CcSEcCtD
Ranolazine—Renal failure—Epirubicin—pancreatic cancer	0.000636	0.00121	CcSEcCtD
Ranolazine—Asthenia—Irinotecan—pancreatic cancer	0.000635	0.00121	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000633	0.00121	CcSEcCtD
Ranolazine—Dysuria—Doxorubicin—pancreatic cancer	0.000628	0.0012	CcSEcCtD
Ranolazine—Dry mouth—Docetaxel—pancreatic cancer	0.000624	0.00119	CcSEcCtD
Ranolazine—Asthenia—Gemcitabine—pancreatic cancer	0.000618	0.00118	CcSEcCtD
Ranolazine—Haematuria—Epirubicin—pancreatic cancer	0.000617	0.00118	CcSEcCtD
Ranolazine—Confusional state—Docetaxel—pancreatic cancer	0.000617	0.00118	CcSEcCtD
Ranolazine—Epistaxis—Epirubicin—pancreatic cancer	0.00061	0.00116	CcSEcCtD
Ranolazine—Pruritus—Gemcitabine—pancreatic cancer	0.00061	0.00116	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—pancreatic cancer	0.000607	0.00116	CcSEcCtD
Ranolazine—Shock—Docetaxel—pancreatic cancer	0.000602	0.00115	CcSEcCtD
Ranolazine—Nervous system disorder—Docetaxel—pancreatic cancer	0.0006	0.00114	CcSEcCtD
Ranolazine—Pruritus—Fluorouracil—pancreatic cancer	0.000599	0.00114	CcSEcCtD
Ranolazine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000599	0.00114	CcSEcCtD
Ranolazine—Skin disorder—Docetaxel—pancreatic cancer	0.000594	0.00113	CcSEcCtD
Ranolazine—Bradycardia—Epirubicin—pancreatic cancer	0.000591	0.00113	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—pancreatic cancer	0.000588	0.00112	CcSEcCtD
Ranolazine—Dizziness—Irinotecan—pancreatic cancer	0.000585	0.00112	CcSEcCtD
Ranolazine—Anorexia—Docetaxel—pancreatic cancer	0.000583	0.00111	CcSEcCtD
Ranolazine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000578	0.0011	CcSEcCtD
Ranolazine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000573	0.00109	CcSEcCtD
Ranolazine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000572	0.00109	CcSEcCtD
Ranolazine—Hypotension—Docetaxel—pancreatic cancer	0.000571	0.00109	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—pancreatic cancer	0.000571	0.00109	CcSEcCtD
Ranolazine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00057	0.00109	CcSEcCtD
Ranolazine—Urethral disorder—Epirubicin—pancreatic cancer	0.000569	0.00108	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—pancreatic cancer	0.000564	0.00108	CcSEcCtD
Ranolazine—Vomiting—Irinotecan—pancreatic cancer	0.000562	0.00107	CcSEcCtD
Ranolazine—Dizziness—Fluorouracil—pancreatic cancer	0.00056	0.00107	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—pancreatic cancer	0.000559	0.00107	CcSEcCtD
Ranolazine—Rash—Irinotecan—pancreatic cancer	0.000558	0.00106	CcSEcCtD
Ranolazine—Dermatitis—Irinotecan—pancreatic cancer	0.000557	0.00106	CcSEcCtD
Ranolazine—Headache—Irinotecan—pancreatic cancer	0.000554	0.00106	CcSEcCtD
Ranolazine—Insomnia—Docetaxel—pancreatic cancer	0.000553	0.00105	CcSEcCtD
Ranolazine—Paraesthesia—Docetaxel—pancreatic cancer	0.000549	0.00105	CcSEcCtD
Ranolazine—Vomiting—Gemcitabine—pancreatic cancer	0.000548	0.00104	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—pancreatic cancer	0.000547	0.00104	CcSEcCtD
Ranolazine—Dyspnoea—Docetaxel—pancreatic cancer	0.000545	0.00104	CcSEcCtD
Ranolazine—Somnolence—Docetaxel—pancreatic cancer	0.000544	0.00104	CcSEcCtD
Ranolazine—Rash—Gemcitabine—pancreatic cancer	0.000543	0.00104	CcSEcCtD
Ranolazine—Dermatitis—Gemcitabine—pancreatic cancer	0.000543	0.00103	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—pancreatic cancer	0.000543	0.00103	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—pancreatic cancer	0.000541	0.00103	CcSEcCtD
Ranolazine—Headache—Gemcitabine—pancreatic cancer	0.00054	0.00103	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000539	0.00103	CcSEcCtD
Ranolazine—Vomiting—Fluorouracil—pancreatic cancer	0.000539	0.00103	CcSEcCtD
Ranolazine—Dyspepsia—Docetaxel—pancreatic cancer	0.000538	0.00103	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000534	0.00102	CcSEcCtD
Ranolazine—Rash—Fluorouracil—pancreatic cancer	0.000534	0.00102	CcSEcCtD
Ranolazine—Dermatitis—Fluorouracil—pancreatic cancer	0.000534	0.00102	CcSEcCtD
Ranolazine—Decreased appetite—Docetaxel—pancreatic cancer	0.000532	0.00101	CcSEcCtD
Ranolazine—Headache—Fluorouracil—pancreatic cancer	0.000531	0.00101	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00053	0.00101	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000529	0.00101	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000528	0.00101	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000528	0.00101	CcSEcCtD
Ranolazine—Fatigue—Docetaxel—pancreatic cancer	0.000527	0.00101	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—pancreatic cancer	0.000527	0.001	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000527	0.001	CcSEcCtD
Ranolazine—Nausea—Irinotecan—pancreatic cancer	0.000525	0.001	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000523	0.000997	CcSEcCtD
Ranolazine—Constipation—Docetaxel—pancreatic cancer	0.000523	0.000997	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—pancreatic cancer	0.000519	0.000989	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—pancreatic cancer	0.000518	0.000987	CcSEcCtD
Ranolazine—Nausea—Gemcitabine—pancreatic cancer	0.000512	0.000976	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—pancreatic cancer	0.000509	0.00097	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—pancreatic cancer	0.000505	0.000963	CcSEcCtD
Ranolazine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000504	0.000961	CcSEcCtD
Ranolazine—Nausea—Fluorouracil—pancreatic cancer	0.000503	0.000959	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—pancreatic cancer	0.000502	0.000957	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—pancreatic cancer	0.000501	0.000955	CcSEcCtD
Ranolazine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.0005	0.000953	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000499	0.00095	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—pancreatic cancer	0.000498	0.000949	CcSEcCtD
Ranolazine—Angiopathy—Doxorubicin—pancreatic cancer	0.000487	0.000929	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—pancreatic cancer	0.000486	0.000926	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000484	0.000923	CcSEcCtD
Ranolazine—Abdominal pain—Docetaxel—pancreatic cancer	0.000483	0.000922	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—pancreatic cancer	0.00048	0.000915	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—pancreatic cancer	0.000476	0.000908	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—pancreatic cancer	0.000471	0.000897	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—pancreatic cancer	0.000468	0.000891	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—pancreatic cancer	0.000461	0.000878	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—pancreatic cancer	0.000454	0.000866	CcSEcCtD
Ranolazine—Syncope—Epirubicin—pancreatic cancer	0.000453	0.000864	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—pancreatic cancer	0.000452	0.000862	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—pancreatic cancer	0.00045	0.000857	CcSEcCtD
Ranolazine—Palpitations—Epirubicin—pancreatic cancer	0.000447	0.000851	CcSEcCtD
Ranolazine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000444	0.000847	CcSEcCtD
Ranolazine—Cough—Epirubicin—pancreatic cancer	0.000441	0.000841	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—pancreatic cancer	0.000441	0.00084	CcSEcCtD
Ranolazine—Asthenia—Docetaxel—pancreatic cancer	0.000439	0.000836	CcSEcCtD
Ranolazine—Pruritus—Docetaxel—pancreatic cancer	0.000433	0.000825	CcSEcCtD
Ranolazine—Anxiety—Epirubicin—pancreatic cancer	0.000429	0.000817	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000427	0.000815	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—pancreatic cancer	0.000421	0.000802	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—pancreatic cancer	0.00042	0.000801	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—pancreatic cancer	0.000419	0.000799	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—pancreatic cancer	0.000419	0.000798	CcSEcCtD
Ranolazine—Confusional state—Epirubicin—pancreatic cancer	0.000416	0.000793	CcSEcCtD
Ranolazine—Palpitations—Doxorubicin—pancreatic cancer	0.000413	0.000788	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000411	0.000784	CcSEcCtD
Ranolazine—Cough—Doxorubicin—pancreatic cancer	0.000408	0.000778	CcSEcCtD
Ranolazine—Shock—Epirubicin—pancreatic cancer	0.000406	0.000774	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000404	0.000771	CcSEcCtD
Ranolazine—Dizziness—Docetaxel—pancreatic cancer	0.000404	0.000771	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000404	0.00077	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—pancreatic cancer	0.000401	0.000764	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000399	0.00076	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—pancreatic cancer	0.000397	0.000756	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000395	0.000754	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—pancreatic cancer	0.000393	0.00075	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—pancreatic cancer	0.000389	0.000742	CcSEcCtD
Ranolazine—Vomiting—Docetaxel—pancreatic cancer	0.000389	0.000741	CcSEcCtD
Ranolazine—Rash—Docetaxel—pancreatic cancer	0.000386	0.000735	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—pancreatic cancer	0.000385	0.000735	CcSEcCtD
Ranolazine—Dermatitis—Docetaxel—pancreatic cancer	0.000385	0.000734	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—pancreatic cancer	0.000385	0.000734	CcSEcCtD
Ranolazine—Headache—Docetaxel—pancreatic cancer	0.000383	0.00073	CcSEcCtD
Ranolazine—Shock—Doxorubicin—pancreatic cancer	0.000375	0.000716	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000374	0.000713	CcSEcCtD
Ranolazine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000374	0.000712	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—pancreatic cancer	0.000373	0.000711	CcSEcCtD
Ranolazine—Skin disorder—Doxorubicin—pancreatic cancer	0.000371	0.000707	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—pancreatic cancer	0.00037	0.000706	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000369	0.000703	CcSEcCtD
Ranolazine—Dyspnoea—Epirubicin—pancreatic cancer	0.000368	0.000701	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—pancreatic cancer	0.000367	0.000699	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—pancreatic cancer	0.000364	0.000694	CcSEcCtD
Ranolazine—Nausea—Docetaxel—pancreatic cancer	0.000363	0.000692	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—pancreatic cancer	0.000363	0.000692	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—pancreatic cancer	0.000359	0.000684	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—pancreatic cancer	0.000357	0.00068	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000356	0.000679	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—pancreatic cancer	0.000356	0.000678	CcSEcCtD
Ranolazine—Constipation—Epirubicin—pancreatic cancer	0.000353	0.000672	CcSEcCtD
Ranolazine—Insomnia—Doxorubicin—pancreatic cancer	0.000345	0.000658	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000343	0.000653	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—pancreatic cancer	0.00034	0.000649	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—pancreatic cancer	0.00034	0.000648	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—pancreatic cancer	0.000339	0.000647	CcSEcCtD
Ranolazine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000337	0.000643	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000336	0.00064	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000332	0.000632	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000329	0.000628	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—pancreatic cancer	0.000329	0.000627	CcSEcCtD
Ranolazine—Urticaria—Epirubicin—pancreatic cancer	0.000328	0.000625	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—pancreatic cancer	0.000326	0.000622	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—pancreatic cancer	0.000326	0.000622	CcSEcCtD
Ranolazine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000314	0.0006	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000312	0.000595	CcSEcCtD
Ranolazine—Urticaria—Doxorubicin—pancreatic cancer	0.000303	0.000578	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000302	0.000575	CcSEcCtD
Ranolazine—Asthenia—Epirubicin—pancreatic cancer	0.000296	0.000564	CcSEcCtD
Ranolazine—Pruritus—Epirubicin—pancreatic cancer	0.000292	0.000556	CcSEcCtD
Ranolazine—Asthenia—Doxorubicin—pancreatic cancer	0.000274	0.000522	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—pancreatic cancer	0.000273	0.00052	CcSEcCtD
Ranolazine—Pruritus—Doxorubicin—pancreatic cancer	0.00027	0.000515	CcSEcCtD
Ranolazine—Vomiting—Epirubicin—pancreatic cancer	0.000262	0.0005	CcSEcCtD
Ranolazine—Rash—Epirubicin—pancreatic cancer	0.00026	0.000496	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—pancreatic cancer	0.00026	0.000495	CcSEcCtD
Ranolazine—Headache—Epirubicin—pancreatic cancer	0.000258	0.000493	CcSEcCtD
Ranolazine—Dizziness—Doxorubicin—pancreatic cancer	0.000252	0.000481	CcSEcCtD
Ranolazine—Nausea—Epirubicin—pancreatic cancer	0.000245	0.000467	CcSEcCtD
Ranolazine—Vomiting—Doxorubicin—pancreatic cancer	0.000243	0.000463	CcSEcCtD
Ranolazine—Rash—Doxorubicin—pancreatic cancer	0.000241	0.000459	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—pancreatic cancer	0.00024	0.000458	CcSEcCtD
Ranolazine—Headache—Doxorubicin—pancreatic cancer	0.000239	0.000456	CcSEcCtD
Ranolazine—Nausea—Doxorubicin—pancreatic cancer	0.000227	0.000432	CcSEcCtD
